Enliven Therapeutics
Price & Volume
Stats
See more52W Range | $13.30-$29.98 |
Market Cap | $1.4B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.81 |
News
See moreYahoo Finance • last month
Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors
Yahoo Finance • 5 months ago
What's going on in today's pre-market session
Yahoo Finance • 5 months ago
Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data
Yahoo Finance • 5 months ago
Enliven files automatic mixed securities shelf
About
CEO | Mr. Richard A. Fair |
CFO | Mr. Benjamin Hohl |
Address | 6200 Lookout Road, Boulder, CO, United States, 80301 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 65 |
